and a list of the evidence used, as a priority so that this can be evaluated by epilepsy experts. We have also sought an assurance that should category three remain, that drugs are only placed on ...

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top ...

More than 50 million people worldwide live with epilepsy, with approximately half of them being children. For about one-third ...

Global Epilepsy Drugs Market is valued at approximately USD $$ billion in 2022 and is anticipated to grow with a healthy growth rate of more than $% over the forecast period 2023-2030. Epilepsy is a ...

Children in England living with a rare and severe form of epilepsy could soon benefit from a new drug being rolled out on the NHS. Fenfluramine has been recommended by the National Institute for ...